<DOC>
	<DOC>NCT02234024</DOC>
	<brief_summary>The purpose of this pilot project is to see if a supplemental form of dietary gangliosides can serve as a potential treatment for the rare metabolic condition called ganglioside GM3 synthase deficiency.</brief_summary>
	<brief_title>Oral Supplementation of Gangliosides to Treat a Rare Metabolic Disorder</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Clinical diagnosis of GM3 synthase deficiency</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>